Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

Yvette Drew, J Ledermann, G Hall, D Rea, R Glasspool, M Highley, Gordon Jayson, J Sludden, J Murray, D Jamieson, S Halford, G Acton, Z Blackholer, R Mangano, A Boddy, N Curtin, R Plummer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbere21
JournalBr J Cancer
Early online date22 Mar 2016
Publication statusPublished - 2016

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this